Works matching AU Moon, Yong Wha

Results: 30

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

Published in:

2013

By:

Yong Wha Moon;
Soohyeon Lee;
Byeong-Woo Park;
Eun-Kyung Kim;
Seung Il Kim;
Ja Seung Koo;
Seho Park;
Min Jung Kim;
Hyun Cheol Chung;
Joo-Hang Kim;
Joohyuk Sohn;
Moon, Yong Wha;
Lee, Soohyeon;
Park, Byeong-Woo;
Kim, Eun-Kyung;
Kim, Seung Il;
Koo, Ja Seung;
Park, Seho;
Kim, Min Jung;
Chung, Hyun Cheol

Publication type:

journal article

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.

Published in:

2016

By:

Arthur Cho;
Jin Hur;
Yong Wha Moon;
Sae Rom Hong;
Young Joo Suh;
Yun Jung Kim;
Dong Jin Im;
Yoo Jin Hong;
Hye-Jeong Lee;
Young Jin Kim;
Hyo Sup Shim;
Jae Seok Lee;
Joo-Hang Kim;
Byoung Wook Choi;
Cho, Arthur;
Hur, Jin;
Moon, Yong Wha;
Hong, Sae Rom;
Suh, Young Joo;
Kim, Yun Jung

Publication type:

journal article

Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics.

Published in:

Genes, 2021, v. 12, n. 2, p. 159, doi. 10.3390/genes12020159

By:

Pandey, Kamal;
Lee, Eunbyeol;
Park, Nahee;
Hur, Jin;
Cho, Young Bin;
Katuwal, Nar Bahadur;
Kim, Seung Ki;
Lee, Seung Ah;
Kim, Isaac;
An, Hee Jung;
Hwang, Sohyun;
Moon, Yong Wha;
Gudjonsson, Thorarinn

Publication type:

Article

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators.

Published in:

Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 3, p. 387, doi. 10.1007/s00432-009-0668-3

By:

Yong Wha Moon;
Sun Young Rha;
Sang Joon Shin;
Hyun Chang;
Hyo Sup Shim;
Jae Kyung Roh

Publication type:

Article

SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancer.

Published in:

Cell Death & Disease, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41419-025-07660-7

By:

Ghosh, Mithun;
Kang, Min Sil;
Katuwal, Nar Bahadur;
Hong, Sa Deok;
Park, Seong Min;
Kim, Seul-Gi;
Lee, Seung Ryeol;
Moon, Yong Wha

Publication type:

Article

Phase II Trial of Irinotecan and Cisplatin With Early Concurrent Radiotherapy in Limited-Disease Small-Cell Lung Cancer.

Published in:

Cancer (0008543X), 2007, v. 109, n. 9, p. 1845, doi. 10.1002/cncr.22621

By:

Joo Hyuk Sohn;
Yong Wha Moon;
Chang Geol Lee;
Gwi Eon Kim;
Kyung Young Chung;
Joon Chang;
Se Kyu Kim;
Young Sam Kim;
Byoung Wook Choi;
Hye Jin Choi;
Joo-Hang Kim

Publication type:

Article

Adenosine Triphosphate-Based Chemotherapy Response Assay (ATP-CRA)-Guided Platinum-Based 2-Drug Chemotherapy for Unresectable NonsmalI-Cell Lung Cancer.

Published in:

Cancer (0008543X), 2007, v. 109, n. 9, p. 1829, doi. 10.1002/cncr.22601

By:

Yong Wha Moon;
Sung He Choi;
Yong Tai Kim;
Joe Hyuk Sohn;
Chang, Joan;
Se Kyu Kim;
Moo Suk Park;
Kyung Young Chung;
Hyoun Ju Lee;
Joe-Hang Kim

Publication type:

Article

Real-World Experience with Pembrolizumab Treatment in Patients with Heavily Treated Recurrent Gynecologic Malignancies.

Published in:

Yonsei Medical Journal, 2020, v. 61, n. 10, p. 844, doi. 10.3349/ymj.2020.61.10.844

By:

Min Chul Choi;
Yong Wha Moon;
Sang Geun Jung;
Park, Hyun;
Won Duk Joo;
Seung Hun Song;
Lee, Chan;
Gwangil Kim;
Kyoung Ah Kim

Publication type:

Article

A Case of Successful Intrapleural Chemotherapy with Cisplatin Plus Cytarabine for Intractable Malignant Pleural Effusion.

Published in:

Yonsei Medical Journal, 2007, v. 48, n. 6, p. 1035, doi. 10.3349/ymj.2007.48.6.1035

By:

Yong Wha Moon;
Sang Tae Choi;
Byoung Chul Cho;
Hye Jin Choi;
Yong Tai Kim

Publication type:

Article

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.

Published in:

2016

By:

Heo, Su;
Jung, Inkyung;
Lee, Choong-kun;
Kim, Jee;
Lim, Sun;
Moon, Yong;
Shim, Hyo;
Jeong, Jaeheon;
Kim, Joo-Hang;
Kim, Hye;
Cho, Byoung;
Heo, Su Jin;
Kim, Jee Hung;
Lim, Sun Min;
Moon, Yong Wha;
Shim, Hyo Sup;
Kim, Hye Ryun;
Cho, Byoung Chul

Publication type:

journal article

Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 797, doi. 10.1007/s00280-010-1295-z

By:

Yong Wha Moon;
Sun Young Rha;
Hei-Cheul Jeung;
Chan Kim;
Min Hee Hong;
Hyun Chang;
Jae Kyung Roh;
Sung Hoon Noh;
Byung Soo Kim;
Hyun Cheol Chung

Publication type:

Article

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 425, doi. 10.1007/s00280-009-1176-5

By:

Yong Wha Moon;
Joo Hyuk Sohn;
Hye Jin Choi;
Hyun Chang;
Byeong-Woo Park;
Seung Il Kim;
Seho Park;
Ja Seung Koo;
Yong Tai Kim;
Jae Kyung Roh;
Hyun Cheol Chung;
Joo-Hang Kim

Publication type:

Article

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989

By:

Kim, Sung-Bae;
Seo, Jae Hong;
Ahn, Jin-Hee;
Kim, Tae-Yong;
Kang, Seok Yun;
Sohn, Joohyuk;
Yang, Yaewon;
Park, Kyong Hwa;
Moon, Yong Wha;
Lim, Seungtaek;
Kang, Myoung Joo;
Yoon, Koung Eun;
Cho, Hyun Ju;
Lee, Keun Seok

Publication type:

Article

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02089-0

By:

Jung, Daun;
Baek, Young Seok;
Lee, In Jee;
Kim, Ki Yeon;
Jang, Heejoo;
Hwang, Sohyun;
Jung, Jieun;
Moon, Yong-wha;
Park, Kyung-Soon;
Choi, Yong-Soo;
An, Hee Jung

Publication type:

Article

Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02089-0

By:

Jung, Daun;
Baek, Young Seok;
Lee, In Jee;
Kim, Ki Yeon;
Jang, Heejoo;
Hwang, Sohyun;
Jung, Jieun;
Moon, Yong-wha;
Park, Kyung-Soon;
Choi, Yong-Soo;
An, Hee Jung

Publication type:

Article

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.

Published in:

Cancers, 2023, v. 15, n. 19, p. 4887, doi. 10.3390/cancers15194887

By:

Jeong, Yeong Gyu;
Katuwal, Nar Bahadur;
Kang, Min Sil;
Ghosh, Mithun;
Hong, Sa Deok;
Park, Seong Min;
Kim, Seul-Gi;
Kim, Tae Hoen;
Moon, Yong Wha

Publication type:

Article

Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase.

Published in:

Cancers, 2022, v. 14, n. 1, p. 210, doi. 10.3390/cancers14010210

By:

Pandey, Kamal;
Katuwal, Nar Bahadur;
Park, Nahee;
Hur, Jin;
Cho, Young Bin;
Kim, Seung Ki;
Lee, Seung Ah;
Kim, Isaac;
Lee, Seung-Ryeol;
Moon, Yong Wha

Publication type:

Article

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence.

Published in:

Cancers, 2020, v. 12, n. 12, p. 3566, doi. 10.3390/cancers12123566

By:

Pandey, Kamal;
Park, Nahee;
Park, Kyung-Soon;
Hur, Jin;
Cho, Yong Bin;
Kang, Minsil;
An, Hee-Jung;
Kim, Sewha;
Hwang, Sohyun;
Moon, Yong Wha

Publication type:

Article

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.

Published in:

Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 3003, doi. 10.1172/JCI73048

By:

Kang-Seo Park;
Raffeld, Mark;
Yong Wha Moon;
Liqiang Xi;
Bianco, Caterina;
Trung Pham;
Lee, Liam C.;
Tetsuya Mitsudomi;
Yasushi Yatabe;
Isamu Okamoto;
Subramaniam, Deepa;
Mok, Tony;
Rosell, Rafael;
Ji Luo;
Salomon, David S.;
Yisong Wang;
Giaccone, Giuseppe

Publication type:

Article

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.

Published in:

Cancer Medicine, 2020, v. 9, n. 17, p. 6234, doi. 10.1002/cam4.3227

By:

Cobb, Patrick Wayne;
Moon, Yong Wha;
Mezei, Klára;
Láng, István;
Bhat, Gajanan;
Chawla, Shanta;
Hasal, Steven J.;
Schwartzberg, Lee S.

Publication type:

Article

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.

Published in:

International Journal of Cancer, 2019, v. 145, n. 5, p. 1179, doi. 10.1002/ijc.32020

By:

Pandey, Kamal;
An, Hee‐Jung;
Kim, Seung Ki;
Lee, Seung Ah;
Kim, Sewha;
Lim, Sun Min;
Kim, Gun Min;
Sohn, Joohyuk;
Moon, Yong Wha

Publication type:

Article

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study).

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061989

By:

Kim, Sung-Bae;
Seo, Jae Hong;
Ahn, Jin-Hee;
Kim, Tae-Yong;
Kang, Seok Yun;
Sohn, Joohyuk;
Yang, Yaewon;
Park, Kyong Hwa;
Moon, Yong Wha;
Lim, Seungtaek;
Kang, Myoung Joo;
Yoon, Koung Eun;
Cho, Hyun Ju;
Lee, Keun Seok

Publication type:

Article

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution.

Published in:

PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0154133

By:

Park, Hyung Soon;
Lim, Sun Min;
Kim, Sora;
Kim, Sangwoo;
Kim, Hye Ryun;
Kwack, KyuBum;
Lee, Min Goo;
Kim, Joo-Hang;
Moon, Yong Wha

Publication type:

Article

Increments of α-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer.

Published in:

Journal of Surgical Oncology, 2009, v. 100, n. 6, p. 459, doi. 10.1002/jso.21347

By:

Moon, Yong Wha;
Rha, Sun Young;
Zhang, Xianglan;
Jeung, Hei-Cheul;
Yang, Woo Ick;
Kwon, Obin;
Jeong, Jae Heon;
Cheon, Sung Hah;
Yoo, Nae Choon;
Chung, Hyun Cheol

Publication type:

Article

Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Enhances Natural Killer Cell Cytotoxicity in HER2-Overexpressing Ovarian Cancer.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 21, p. 11733, doi. 10.3390/ijms252111733

By:

Hong, Sa Deok;
Katuwal, Nar Bahadur;
Kang, Min Sil;
Ghosh, Mithun;
Park, Seong Min;
Kim, Tae Hoen;
Baek, Young Seok;
Lee, Seung Ryeol;
Moon, Yong Wha

Publication type:

Article

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 17086, doi. 10.3390/ijms242317086

By:

Ghosh, Mithun;
Kang, Min Sil;
Katuwal, Nar Bahadur;
Hong, Sa Deok;
Jeong, Yeong Gyu;
Park, Seong Min;
Kim, Seul-Gi;
Moon, Yong Wha

Publication type:

Article

Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1223, doi. 10.3390/ijms22031223

By:

Hur, Jin;
Ghosh, Mithun;
Kim, Tae Heon;
Park, Nahee;
Pandey, Kamal;
Cho, Young Bin;
Hong, Sa Deok;
Katuwal, Nar Bahadur;
Kang, Minsil;
An, Hee Jung;
Moon, Yong Wha

Publication type:

Article

First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2022, v. 40, n. 5, p. 1001, doi. 10.1007/s10637-022-01277-9

By:

Janku, Filip;
Beom, Seung-Hoon;
Moon, Yong Wha;
Kim, Tae Won;
Shin, Young G.;
Yim, Dong-Seok;
Kim, Gun Min;
Kim, Hyo Song;
Kim, Sun Young;
Cheong, Jae-Ho;
Lee, Young Woo;
Geiger, Barb;
Yoo, Sanghee;
Thurston, Archie;
Welsch, Dean;
Rudoltz, Marc S.;
Rha, Sun Young

Publication type:

Article

Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 3, p. 766, doi. 10.4143/crt.2022.987

By:

Yong Wha Moon;
Seung Ki Kim;
Keun Seok Lee;
Moon Hee Lee;
Yeon Hee Park;
Kyong Hwa Park;
Gun Min Kim;
Seungtaek Lim;
Seung Ah Lee;
Jae Duk Choi;
Eunhye Baek;
Hyesun Han;
Seungjae Baek;
Seock-Ah Im

Publication type:

Article

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02903-x

By:

Katuwal, Nar Bahadur;
Kang, Min Sil;
Ghosh, Mithun;
Hong, Sa Deok;
Jeong, Yeong Gyu;
Park, Seong Min;
Kim, Seul-Gi;
Sohn, Joohyuk;
Kim, Tae Hoen;
Moon, Yong Wha

Publication type:

Article